Drug Safety

Safety of Thrombolysis during Cardiopulmonary Resuscitation
pp. 367-379(13)
Authors: Spöhr F.; Böttiger B.W.

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease
pp. 381-403(23)
Authors: Wagena E.J.; Zeegers M.P.A.; van Schayck C.P.; Wouters E.F.M.

A Benefit-Risk Assessment of Ofloxacin Otic Solution in Ear Infection
pp. 405-420(16)
Authors: Wai T.K.H.; Tong M.C.F.

Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs
pp. 421-438(18)
Authors: Yamreudeewong W.; DeBisschop M.; Martin L.G.; Lower D.L.

Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s Disease: A Meta-Analysis
pp. 439-444(6)
Authors: Etminan M.; Gill S.; Samii A.